Global Local Anesthetics Market, By Application (General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, Others), Drug Type (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Articaine, Benzocaine, Others), Dosage (Liquids, Creams, Gels, Sprays, Patches, Injectables), Route Of Administration (Inhalation, Intravenous, Topical), Demographic (Pediatric, Adults, Geriatric), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029.
Global Local Anesthetics Market Analysis and Size
In recent years, the local anesthetics? market is anticipated to grow rapidly during the forecast period. Over the study period, a rising number of surgeries was a prominent factor driving market expansion. According to the Plastic Surgery Statistics Report, the total number of cosmetic treatments performed in 2020 in the United States was 2,314,720, including 211,067 liposuction procedures. Because local anaesthetic is commonly utilized in these procedures, the demand for anaesthesia medicines will rise as the number of such surgeries increases. Hence this led to the high demand of local anesthetics in the market.
- Data Bridge Market Research analyses that the local anesthetics? market was valued at USD 9.24 billion in 2021 and is expected to reach USD 13.34 billion by 2029, registering a CAGR of 4.70% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Global Local Anesthetics Market Definition
A local anaesthetic is a type of drug that is used to numb a specific part of the body. These medications can be used to treat painful disorders, prevent pain during procedures or operations, and relieve pain following surgery. Local anaesthetics prevent nerves in a specific area of your body from transmitting impulses to your brain. Dentists, surgeons, anaesthetists, GPs, and other doctors are the most common providers of local anaesthetics. Prescription or over-the-counter medications with moderate local anaesthesia are also available from pharmacies. Local anaesthetics can be delivered as injections, creams, gels, sprays, or ointments, depending on the use.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Application (General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, Others), Drug Type (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Articaine, Benzocaine, Others), Dosage (Liquids, Creams, Gels, Sprays, Patches, Injectables), Route Of Administration (Inhalation, Intravenous, Topical), Demographic (Pediatric, Adults, Geriatric), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
B. Braun Melsungen AG (Germany), Baxter (US), AstraZeneca (UK), AbbVie Inc. (US), Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Eisai Co., Ltd. (Japan), Aspen Holdings (South Africa), Boehringer Ingelheim International GmbH. (Germany), bela-pharm GmbH & Co. KG (Germany), Fresenius SE & Co. KGaA (Germany), Pacira Pharmaceuticals Inc. (US), Septodont Holding (France), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd.(Jerusalem), Pfizer Inc. (US), Pierrel (Italy), Sagent Pharmaceutical, Inc. (US), Sanofi (France), Novartis AG (Switzerland)
|
|
Market Opportunities
|
|
Local Anesthetics? Market Dynamics
Drivers
-
Increasing Number of Surgeries
The rising number of surgeries such as dental procedures, cosmetic surgeries, and plastic surgeries is a primary driver of the local anesthetics? market's growth. The increasing incidents of injuries and accidents results in the requirement for surgeries and hence will further influence the market dynamics during the forecast period.
-
Increasing Investment for Healthcare Infrastructure
Another significant factor influencing the growth rate of the local anesthetics? market is the rising healthcare expenditure which helps in improving its infrastructure.
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the local anesthetics? market. Additionally, high disposable income and increasing use of local anesthetics for post-operative pain will result in the expansion of local anesthetics? market. Along with this, rising geriatric population and surging prevalence of cardiovascular and respiratory system-related diseases will enhance the growth rate of the market.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the local anesthetics? market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the local anesthetics? market growth during the forecast period.
Restraints/Challenges Global Local Anesthetics Market
On the other hand, the high cost associated with the local anesthetics? will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the local anesthetics? market. Additionally, strict guidelines, as well as regulations and side effects linked with the administration of local anesthetics? such as pain, dizziness, muscle twitching, weakness, vomiting and others, will act as market restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This local anesthetics? market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the local anesthetics? market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Local anesthetics? market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Local Anesthetics? Market
The use of local anaesthetic in the treatment of COVID-19-infected patients is in increasing demand because of its advantages and low risk of viral transmission. Furthermore, according to an article titled "Topical Lignocaine Anesthesia for Oropharyngeal Sampling for COVID-19" published in October 2020, topical oropharyngeal lignocaine applications significantly increased patient comfort levels during oropharyngeal sampling for COVID-19 and did not affect the detection of SARS-CoV-2 in the upper airway. As a result, the study concluded that topical oropharyngeal lignocaine could be used to reduce viral inoculum sampling in people who are suspected of being infected with COVID-19. Such research is anticipated to increase the usage of local anaesthetic medicines in the treatment of COVID-19 patients around the world.
Recent Development
- In January 2021, Laboratoires Théa SAS (Théa) has agreed to buy seven branded ophthalmic products from Akorn Operating Firm LLC, Europe's foremost independent pharmaceutical company focusing in the research, development, and commercialization of eye-care products. Théa will be able to add Akorn branded products to its portfolio, including Akten (lidocaine HCl ophthalmic gel), a local anaesthetic intended for ocular surface anaesthetic during ophthalmologic operations, as a result of the strategic move.
Global Local Anesthetics? Market Scope
The local anesthetics? market is segmented on the basis of application, drug type, demographic, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Application
- General Surgeries
- Plastic Surgery
- Cosmetic Surgeries
- Dental Surgeries
- Others
On the basis of application, the global hepatic drugs market is segmented into general surgeries, plastic surgery, cosmetic surgeries, dental surgeries and others.
Drug Type
- Bupivacaine
- Ropivacaine
- Lidocaine
- Chloroprocaine
- Articaine
- Benzocaine
- Others
On the basis of drug type, the global hepatic drugs market is segmented into bupivacaine, ropivacaine, lidocaine, chloroprocaine, articaine, benzocaine, and others.
Demographic
- Pediatric
- Adults
- Geriatric
On the basis of demographic, the local anesthetics? market is segmented into pediatric, adults, and geriatric.
Dosage
- Liquids
- Creams
- Gels
- Sprays
- Patches
- Injectables
On the basis of dosage, the local anesthetics? market is segmented into liquids, creams, gels, sprays, patches, and injectables.
Route of Administration
- Inhalation
- Intravenous
- Topical
The route of administration segment for the local anesthetics? market is segmented into inhalation, intravenous, and topical.
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
On the basis of end-users, the local anesthetics? market is segmented into hospitals, specialty clinics, homecare and others.
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
On the basis of distribution channel, the local anesthetics? market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.
Local Anesthetics? Market Regional Analysis/Insights
The Local anesthetics? market is analysed and market size insights and trends are provided by country, application, drug type, demographic, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the Local anesthetics? market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the local anesthetics? market because of the growing number of patients suffering from cardiovascular and respiratory system-related diseases in this region. Additionally, growing presence of major key players will further propel the market’s growth rate in this region.
Asia-Pacific are expected to grow during the forecast period of 2022 to 2029 due to rising healthcare expenditure and improvements in healthcare infrastructure in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Local Anesthetics? Market Share Analysis
The Local anesthetics? market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to local anesthetics? market.
Some of the major players operating in the local anesthetics? market are:
- B. Braun Melsungen AG (Germany)
- Baxter (US)
- AstraZeneca (UK)
- AbbVie Inc. (US)
- Abbott (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Eisai Co., Ltd. (Japan)
- Aspen Holdings (South Africa)
- Boehringer Ingelheim International GmbH. (Germany)
- bela-pharm GmbH & Co. KG (Germany)
- Fresenius SE & Co. KGaA (Germany)
- Pacira Pharmaceuticals Inc. (US)
- Septodont Holding (France)
- Mylan N.V. (US)
- Teva Pharmaceutical Industries Ltd.(Jerusalem)
- Pfizer Inc. (US)
- Pierrel (Italy)
- Sagent Pharmaceutical, Inc. (US)
- Sanofi (France)
- Novartis AG (Switzerland)
SKU-